This past Sunday was the Alzheimer's Association International Conference, and at this conference two new drugs were presented. These drugs have shown a bit of promise in early tests and will likely be tested in the next round of clinical trials. Researchers are hopeful that these drugs will advance farther than others have, making to the marketplace, but aren't holding their breaths for it. To read more about these two drugs, check out this article in Everyday Health.